39 related articles for article (PubMed ID: 24770866)
1. Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.
Gronwald J; Huzarski T; Byrski B; Medrek K; Menkiszak J; Monteiro AN; Sun P; Lubinski J; Narod SA
J Med Genet; 2006 May; 43(5):424-8. PubMed ID: 16227521
[TBL] [Abstract][Full Text] [Related]
2. TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.
Kringen P; Wang Y; Dumeaux V; Nesland JM; Kristensen G; Borresen-Dale AL; Dorum A
BMC Cancer; 2005 Oct; 5():134. PubMed ID: 16229746
[TBL] [Abstract][Full Text] [Related]
3. Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine.
Samusieva A; Serga S; Klymenko S; Rybchenko L; Klimuk B; Zakhartseva L; Gorovenko N; Lobanova O; Rossokha Z; Fishchuk L; Levkovich N; Medvedieva N; Popova O; Cheshuk V; Inomistova M; Khranovska N; Skachkova O; Michailovich Y; Ponomarova O; Kozeretska I
Breast Cancer Res Treat; 2022 Oct; 195(3):453-459. PubMed ID: 35930098
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update.
Savanevich A; Ashuryk O; Cybulski C; Lubiński J; Gronwald J
Hered Cancer Clin Pract; 2021 Jan; 19(1):13. PubMed ID: 33478551
[TBL] [Abstract][Full Text] [Related]
5. Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis.
Mikhaylenko DS; Tanas AS; Zaletaev DV; Nemtsova MV
J Oncol; 2020; 2020():7363102. PubMed ID: 32612654
[TBL] [Abstract][Full Text] [Related]
6. The contribution of BRCA1 and BRCA2 to ovarian cancer.
Ramus SJ; Gayther SA
Mol Oncol; 2009 Apr; 3(2):138-50. PubMed ID: 19383375
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 founder mutations compared to ovarian cancer in Belarus.
Savanevich A; Oszurek O; Lubiński J; Cybulski C; Dębniak T; Narod SA; Gronwald J
Fam Cancer; 2014 Sep; 13(3):445-7. PubMed ID: 24770866
[TBL] [Abstract][Full Text] [Related]
8. The contribution of founder mutations in BRCA1 to breast cancer in Belarus.
Uglanitsa N; Oszurek O; Uglanitsa K; Savonievich E; Lubiński J; Cybulski C; Debniak T; Narod SA; Gronwald J
Clin Genet; 2010 Oct; 78(4):377-80. PubMed ID: 20507347
[TBL] [Abstract][Full Text] [Related]
9. High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.
Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Hillemanns P; Dörk T
Clin Genet; 2010 Oct; 78(4):364-72. PubMed ID: 20569256
[TBL] [Abstract][Full Text] [Related]
10. The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania.
Elsakov P; Kurtinaitis J; Petraitis S; Ostapenko V; Razumas M; Razumas T; Meskauskas R; Petrulis K; Luksite A; Lubiński J; Górski B; Narod SA; Gronwald J
Clin Genet; 2010 Oct; 78(4):373-6. PubMed ID: 20345474
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia.
Plakhins G; Irmejs A; Gardovskis A; Subatniece S; Rozite S; Bitina M; Keire G; Purkalne G; Teibe U; Trofimovics G; Miklasevics E; Gardovskis J
BMC Med Genet; 2011 Oct; 12():147. PubMed ID: 22032251
[TBL] [Abstract][Full Text] [Related]
12. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
13. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Finch AP; Lubinski J; Møller P; Singer CF; Karlan B; Senter L; Rosen B; Maehle L; Ghadirian P; Cybulski C; Huzarski T; Eisen A; Foulkes WD; Kim-Sing C; Ainsworth P; Tung N; Lynch HT; Neuhausen S; Metcalfe KA; Thompson I; Murphy J; Sun P; Narod SA
J Clin Oncol; 2014 May; 32(15):1547-53. PubMed ID: 24567435
[TBL] [Abstract][Full Text] [Related]
14. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Zhang S; Royer R; Li S; McLaughlin JR; Rosen B; Risch HA; Fan I; Bradley L; Shaw PA; Narod SA
Gynecol Oncol; 2011 May; 121(2):353-7. PubMed ID: 21324516
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
